EIisa –a connected, affordable light solution for treating sleep apnea.

Informations projet

SUNRISE Tx

N° de convention de subvention: 190180051

DOI

10.3030/190180051

Projet clôturé

Date de signature de la CE 29 Juin 2022

Date de début 1 Juillet 2022

Date de fin 31 Decembre 2024

Financé au titre de

• The European Innovation Council (EIC)

Coût total

€ 2 771 250,78

Contribution de l’UE

€ 1 939 875,00

Coordonné par

SUNRISE
Belgium

Periodic Reporting for period 2 - SUNRISE Tx (EIisa –a connected, affordable light solution for treating sleep apnea.)

Période du rapport: 2023-07-01 au 2024-12-31

Résumé du contexte et des objectifs généraux du projet

Sleep apnea is a common sleep disorder characterized by repeated interruptions in breathing during sleep. It is a major comorbidity of cardiovascular disease and a significant risk factor for type 2 diabetes, stroke, coronary artery disease, congestive heart failure, and atrial fibrillation, among other conditions. The current gold standard treatment relies on positive airway pressure (PAP) devices, which often cause discomfort, as they require patients to wear a face mask connected to a hose throughout the night. The Sunrise Tx project introduces the first truly comfortable, non-invasive, cost-effective, and accessible solution for sleep apnea treatment. Sunrise Tx is designed to broaden access to personalized therapy, improve patient compliance, and provide millions of people worldwide with a more comfortable and effective solution for managing their sleep apnea.

Travail effectué depuis le début du projet jusqu’à la fin de la période considérée dans le rapport et principaux résultats atteints jusqu’à présent

The activities focused on refining the design and enhancing patient comfort for the Sunrise Tx device. Through extensive research and multiple design iterations, significant advancements were achieved, resulting in a markedly improved user experience. A rigorous clinical validation process was implemented to thoroughly assess the device’s efficacy and safety. The validation results demonstrated strong clinical value, earning widespread support from the medical community.

Progrès au-delà de l’état des connaissances et impact potentiel prévu (y compris l’impact socio-économique et les conséquences sociétales plus larges du projet jusqu’à présent)

The Sunrise Tx project surpasses the current state of the art in sleep apnea treatment by offering a non-invasive, cost-effective, and patient-centered solution that overcomes the limitations of conventional PAP therapies. Building on its validated efficacy and safety, the device integrates innovative design and personalized therapy to significantly enhance comfort, usability, and patient compliance, addressing key barriers to long-term adherence. Beyond improving the user experience, Sunrise Tx expands access to effective care, providing a practical and scalable solution for millions of patients. By combining technological innovation with a patient-centric approach, Sunrise Tx represents a transformative advancement in sleep apnea management, setting a new standard in therapeutic care.

SUNRISE logo